SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

MERSANA THERAPEUTICS, INC. (MRSN)

MRSN RSS Feed
Add MRSN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/29/2017 3:25:11 PM - Followers: 3 - Board type: Free - Posts Today: 0

Mersana Therapeutics, Inc. is a biotechnology company that discovers, engineers, and develops antibody drug conjugates to cure various cancers. The company develops immune conjugate therapies to create drugs that enhance patients’ lives. It offers XMT-1522, a drug therapy for tumor models that express relatively low amounts of the HER2 protein; and human anti-HER2 antibody used in XMT-1522. Mersana Therapeutics, Inc. has strategic alliances with Takeda Pharmaceutical Company Limited; Merck Serono; and Asana BioSciences. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.
SureTrader
Interactive Brokers Advertisement
MRSN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
MRSN News: Mersana Therapeutics Added to NASDAQ Biotechnology Index 12/15/2017 08:00:00 AM
MRSN News: Mersana Announces First Patient Dosed with XMT-1536 in Phase 1 Study in Patients with NaPi2b-Expressing Tumors 12/12/2017 08:00:00 AM
MRSN News: Quarterly Report (10-q) 11/13/2017 06:07:11 AM
MRSN News: Current Report Filing (8-k) 11/09/2017 04:19:07 PM
MRSN News: Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates 11/09/2017 04:01:00 PM